1. Carrier–Tumor Cell Membrane Interactions for Optimized Delivery of a Promising Drug, 4(RS)-4-F4t-Neuroprostane
   Ariana Abawi et al, 2023, Pharmaceutics CrossRef
2. Dual targeting of the androgen receptor and PI3K/AKT/mTOR pathways in prostate cancer models improves antitumor efficacy and promotes cell apoptosis
   Tatsuo Sugawara et al, 2024, Molecular Oncology CrossRef
3. Metabolic Vulnerabilities in Cancer: A New Therapeutic Strategy
   Mohamed El-Tanani et al, 2024, Critical Reviews in Oncology/Hematology CrossRef
4. Raman spectroscopy reveals oxidative stress-induced metabolic vulnerabilities in early-stage AR-negative prostate-cancer versus normal-prostate cell lines
   M. Cameron et al, 2024, Sci Rep CrossRef
5. Novel lipid metabolism factor HIBCH inhibitor synergizes with doxorubicin to suppress osteosarcoma growth and impacts clinical prognosis in osteosarcoma patients
   Xuhui Yuan et al, 2024, Journal of Bone Oncology CrossRef
6. Altered amino and fatty acids metabolism in Sudanese prostate cancer patients: insights from metabolic analysis
   Dalia Ahmed et al, 2024, J Circ Biomark CrossRef
7. Combined Blockade of Lipid Uptake and Synthesis by CD36 Inhibitor and SCD1 siRNA Is Beneficial for the Treatment of Refractory Prostate Cancer
   Jiyuan Chen et al, 2024, Advanced Science CrossRef